title: Kinetic analysis of the conjugation of ubiquitin to picornavirus 3C proteases catalyzed by the mammalian ubiquitin-protein ligase E3alpha.
abstract: The 3C proteases of the encephalomyocarditis virus and the hepatitis A virus are both type III substrates for the mammalian ubiquitin-protein ligase E3alpha. The conjugation of ubiquitin to these proteins requires internal ten-amino acid-long protein destruction signal sequences. To evaluate how these destruction signals modulate interactions that must occur between E3alpha and the 3C proteases, we have kinetically analyzed the formation of ubiquitin-3C protease conjugates in a reconstituted system of purified E1, HsUbc2b/E2(14Kb), and human E3alpha. Our measurements show that the encephalomyocarditis virus 3C protease is ubiquitinated in this system with K(m) = 42 +/- 11 microm and V(max) = 0.051 +/- 0.01 pmol/min whereas the parameters for the ubiquitination of the hepatitis A virus 3C protease are K(m) = 20 +/- 5 microm and V(max) = 0.018 +/- 0.003 pmol/min. Mutations in the destruction signal sequences resulted in changes in the rate at which E3alpha conjugates ubiquitin to the altered 3C protease proteins. The K(m) and V(max) values for these reactions change proportionally in the same direction. These results suggest differences in rates of conjugation of ubiquitin to 3C proteases are primarily a k(cat) effect. Replacing specific encephalomyocarditis virus 3C protease lysine residues with arginine residues was found to increase, rather than decrease, the rate of ubiquitin conjugation, and the K(m) and V(max) values for these reactions are both higher than for the wild type protein. The ability of E3alpha to catalyze the conjugation of ubiquitin to both 3C proteases was found to be inhibited by lysylalanine and phenylalanylalanine, demonstrating that the same sites on E3alpha that bind destabilizing N-terminal amino acids in type I and II substrates also interact with the 3C proteases.
authors.affiliation: Department of Chemistry, Bates College, Lewiston, Maine 04240, USA. tlawson@bates.edu
authors.forename: T G
authors.initials: TG
authors.lastname: Lawson
authors.forename: M E
authors.initials: ME
authors.lastname: Sweep
authors.forename: P E
authors.initials: PE
authors.lastname: Schlax
authors.forename: R N
authors.initials: RN
authors.lastname: Bohnsack
authors.forename: A L
authors.initials: AL
authors.lastname: Haas
mesh_terms: D000086042:3C Viral Proteases; D001120:Arginine / Q000235:genetics; D002474:Cell-Free System; D003546:Cysteine Endopeptidases / Q000235:genetics / Q000378:metabolism*; D004686:Encephalomyocarditis virus / Q000201:enzymology; D030041:Hepatitis A virus / Q000201:enzymology; D006801:Humans; D007700:Kinetics; D008025:Ligases / Q000378:metabolism*; D008239:Lysine / Q000235:genetics; D009154:Mutation; D010849:Picornaviridae / Q000201:enzymology*; D013379:Substrate Specificity; D025801:Ubiquitin / Q000378:metabolism*; D044767:Ubiquitin-Protein Ligases; D014764:Viral Proteins / Q000235:genetics / Q000378:metabolism*
chemical_list: D025801:Ubiquitin; D014764:Viral Proteins; D001120:Arginine; D044767:Ubiquitin-Protein Ligases; D003546:Cysteine Endopeptidases; D000086042:3C Viral Proteases; D008025:Ligases; D008239:Lysine